ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

SAKUNTALAI SRINANTHAKUMAR M.D.

At A Glance: This Prescriber in 2012

Adult Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,460Medicare Part D Prescriptions Filled, Including Refills

Rank: 19 out of 59

$696K Total Retail Price of All Prescriptions

Rank: 14 out of 59

372 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
21% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Texas
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

10% of this provider’s 372 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

1% of this provider’s 6,981 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

36% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$93 was the average price of a prescription from this provider, compared to $71 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Texas
SIMVASTATIN 321 296 1 1
ATORVASTATIN CALCIUM 218 217 2 15
METFORMIN HCL 202 196 3 6
LEVOTHYROXINE SODIUM 196 190 4 3
ESCITALOPRAM OXALATE 180 162 5 76
PANTOPRAZOLE SODIUM 165 157 6 33
LISINOPRIL 159 155 7 2
CRESTOR 157 125 8 23
NEXIUM 155 145 9 14
AMLODIPINE BESYLATE 143 132 10 4
ZOLPIDEM TARTRATE 136 132 11 17
LISINOPRIL-HYDROCHLOROTHIAZIDE 133 133 12 18
BENICAR HCT 123 117 13 169
GABAPENTIN 122 117 14 13
FLUTICASONE PROPIONATE 118 108 15 34
SERTRALINE HCL 109 100 16 22
PRAVASTATIN SODIUM 108 108 17 21
JANUVIA 102 99 18 45
OMEPRAZOLE 99 91 19 7
DIOVAN 97 90 20 38
FENOFIBRATE 95 91 21 86
CEPHALEXIN 92 88 22 112
SYNTHROID 82 79 23 100
DIOVAN HCT 82 82 23 65
HYDROCHLOROTHIAZIDE 81 77 25 11
CARVEDILOL 79 66 26 31
PREDNISONE 77 73 27 40
LEVOFLOXACIN 76 72 28 84
MELOXICAM 74 73 29 26
METOPROLOL SUCCINATE 73 64 30 12
POTASSIUM CHLORIDE 72 55 31 16
CITALOPRAM HBR 72 64 31 25
MONTELUKAST SODIUM 72 67 31 202
FUROSEMIDE 66 58 34 8
DONEPEZIL HCL 60 60 35 24
LOVASTATIN 58 51 36 43
SINGULAIR 55 51 37 85
HYDROCODONE-ACETAMINOPHEN 54 50 S3 38 5
CIPROFLOXACIN HCL 54 51 38 36
LIPITOR 50 50 40 83
TAMSULOSIN HCL 50 50 40 27
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.